INTRODUCTION
A widespread epidemic of HFMD took place in Japan in 1973 (Tagaya and Tachibana, 1975) , the causative agent of which was identified as EV71 (Hagiwara , Tagaya and Yoneyama, 1978a) . Since it was found that the virus isolates had a common antigen with Coxsackievirus A 16 detectable by the immuno-fluorescence test (Hagiwara, Tagaya and Yoneyama, 1978b) , they were considered as an antigenic variant of Coxsackievirus A 16. Afterwards , however, it became clear that they were antigenically identical with the new enterovirus reported by Schmidt, Lennet and Ho (1974) and later designated as enterovirus 71 (Melnick , Tagaya and von Magnus, 1974) . Therefore, it was concluded that the widespread outbreaks of HFMD in 1973 were due to enterovirus 71 infection (Hagiwara et al., 1978a) .
The 1973 epidemic of HFMD was ascertained here by Miwa et al . (1978a) to have been due to EV71 as a part of the nationwide epidemic . Another epidemic of HFMD recurred here in 1975, and it was found that Coxsackie A16 virus was responsible (Miwa et al., 1978b (Hagiwara et al., 1978a) and Vero cells were used. For titration of the neutralization antibody, CMK cells were used.
The growth medium for MK cells consisted of a mixture of Dulbecco's YLE and Eagle's minimal essential medium (MEM) (Nissui Seiyaku Co., Tokyo) supplemented with 5% newborn calf serum (Flow Lab., Australia), 0.075% sodium bicarbonate and antibiotics. The growth medium for CMK and Vero cells consisted of MEM, 10% newborn calf serum, 0.075% sodium bicarbonate and antibiotics.
The maintenance medium for MK cells consisted of a mixture of YLE and MEM with 0.22% sodium bicarbonate and antibiotics, and that for CMK and Vero cells consisted of MEM with 2% newborn calf serum, 0.22% sodium bicarbonate and antibiotics.
Virus isolation: Throat swabs and vesicle fluid were collected on cottontipped applicators and each was put in a tube containing 3 ml of MEM containing 500 units/ml of penicillin and 500 pug/ml of streptomycin. The tubes were rubber-stoppered and kept frozen in a deep freezer below -20 C. Antibiotics only was added to CSF. The extract of throat specimens, vesicle fluid and CSF were centrifuged at 2,500 rpm for 10 min and the supernatant was used as inoculum. A 10% suspension of the feces was prepared in MEM similarly as above, centrifuged at 2,500 rpm for 20 min and the supernatant was used as inoculum.
Two tubes of each cell culture were inoculated with 0.2 ml of all the clinical specimen except feces which was inoculated in 0.1 ml. The tubes whose cytopathic effect (CPE) was not clear or negative were frozen and thawed 3 times and the supernatant obtained by centrifugation at 2,500 rpm for 10 min was inoculated for blind passages. Tubes showing no CPE after four passages in CMK cells and two passages in MK and Vero cells were considered to be negative in virus isolation. In MK and Vero cells, tubes showing CPE (± or 1 +) were passaged in CMK cells once or twice and tubes showing clear CPE were considered to be positive. The specimens yielding coxsackievirus B 1 were each added to 0.5 ml of 1,000 unit coxsackievirus B1 antiserum for neutralization and re-isolation was tried in CMK cells.
Titration o f virus in f ectivity: The isolated virus was diluted 10-fold, 0.2 ml of which was inoculated into each of two tubes containing 1 ml of the maintenance medium and they were placed in stationary racks at 37 C. Observation was made daily for 6-7 days and 50% endpoints were calculated by the formula of Reed and Muench (1938) .
Identification o f the isolated viruses: The isolates were identified by the neutralization test employing 100 units of rabbit antiserum against EV71 prototype strain (BrCr). The isolates which were not identified with the above antiserum were identified by the neutralization test employing immune serum pools prepared according to a modification of "intersecting serum scheme" of Schmidt, Guenther and Lennette (1961) or type-specific monovalent antisera. Pools of the intersecting serum scheme consisted of type-specific antisera against polio 1-3, echo 1-7, 9, 11-27, and 29-33, coxsackie A7 and 9, coxsackie B 1-6 and reo 1 viruses.
For identification of the isolates, 0.3 ml of an appropriate dilution of the antiserum and the same volume of the isolate containing approximately 100 TCID50 were mixed. The mixture was incubated in a water bath at 37 C for 2 hr, 0.2 ml of which was inoculated into each of two cell culture tubes with 1 ml of the fresh maintenance medium.
Titration of neutralization antibody in patient's serum: The SY-V strain, isolated from vesicle fluid of an HFMD patient in 1978, was used as the challenge virus. After isolation in Vero cells, the cytopathic agent was passaged once in CMK cells. A 0.3-m1 portion of the virus dilution containing 100 TCID50 per 0.1 ml was mixed with the equal volume of patient's serum serially diluted by fourfold steps. The mixtures were incubated at 37 C for 2 hr in a water bath and inoculated into two CMK cell culture tubes each with 1 ml of the fresh maintenance medium. After 7 days' incubation at 37 C, the results were read and 50% neutralizing endpoints were calculated by the method of Reed and Muench (1938) . The titers were expressed as reciprocals of the highest serum dilutions before mixed with virus showing the neutralization activity.
RESULTS

The Outlook o f Epidemic o f HFMD
The information of patients with HFMD was collected by Epidemiological Study Section, Preventive Health Division of Gifu Prefecture. By the information, 2,446 patients were confirmed clinically. Such unreliable information that lacked description concerning age and date of onset of illness was discarded, so 2,374 cases were investigated epidemiologically. The monthly incidence is shown in Fig. 1 . The first patient with HFMD was found on 15 May. However, in our laboratory we confirmed a patient with HFMD in Takayama area on 29 April. The epidemic of HFMD lasted from May to August, during which period the peak months were June and July. As shown in Fig. 2 ranged from 0 to 31 years of age, but 80.2% of them were under 5 years' old. The maximum number of the patients was found in 3 years of age and was followed by patients whose ages were 2 and 4 years' old. The sex ratio between males and females was 1.18:1.00, and hence, the difference was not distinct. Virus isolation was attempted on clinical specimens from 108 cases, and 83 of them yielded CPE agents (76.9%). EV71 alone was isolated from 81 cases of them (75.0%). EV71 and coxsackievirus B1 were recovered from another case, and coxsackievirus B1 only was isolated from the other case. The results of virus isolation are shown in Table I . From specimens of throat swabs and vesicle fluid, respectively 35 and 59 strains of EV71 were isolated. From specimens of feces, 47 strains of EV71 were isolated, coxsackievirus B1 and EV71 were mix-isolated from one case and coxsackievirus Bl only from another case. No virus was isolated from CSF.
As shown in Table II , CMK, MK and Vero cells showed significantly different isolation rates of the virus; that of CMK was as high as 53.4%, whereas that of Vero cells was as low as 2.4%. Appearance of CPE in CMK was faster and clearer than that in MK. Therefore, after one or two passages in MK cells, CMK was employed to confirm CPE. The isolation rates of EV71 from specimens in MK and CMK cells are shown in Table III . A large number of viruses were isolated in CMK cells from various clinical specimens, although the isolation rates were different. CMK cells contributed greatly to virus isolation The relation between isolation of EV71 from specimens and days after the onset of illness is shown in Table IV . From throat swab specimens, the virus was isolated until the 5th days after the onset. The viruses were isolated from vesicle fluid and feces until the 8th and the 13th days after the onset, respec- 
Antibody Response of Patients against Enterovirus 71
Neutralization antibody titers of 25 pair sera were examined with the SY-V strain, the 1978 isolate from an HFMD case. As shown in Table V , a significant rise in the neutralizing antibody titer was found in 14 of 25 pairs (56%). Of these 14 cases, 12 yielded EV71 from their specimens, therefore, their EV71 infection was confirmed virologically as well as serologically. In spite of the significant rise in the neutralizing antibody titer, however, no virus was isolated from the patient 24 and coxsackievirus B 1 alone was isolated from the patient 17. For the latter, 1,000 units of coxsackievirus B 1 antiserum was added to each of the specimens and re-isolation of virus was tried but no EV71 could be isolated. EV71 infection of the two cases was confirmed serologically. All cases tested had the antibody against EV71 in convalescence. Tables VI and VII. Of 351 HFMD patients, 13 (3.7%) were complicated with CNS disease. All the cases were found to be under 5 years of age. Of the 13 cases, all (100%) had fever higher than 37 C, eight (61.5%) vomiting, seven (53.8%) convulsion, and seven (53.8%) nuchal rigidity. Headache was unknown in three infants under one year of age, but it occurred in eight cases (80%) of children of the age group above 2 years. Nine cases (69.2%) had the maximal temperature higher than 38.5 C. The duration of fever higher than 37 C was 1 to 18 days, mostly less than 7 days. CSF was examined on account of these signs and symptoms: pleocytosis was found in all examined. Figure 4 shows data concerning the onset of symptoms of neurological complication in relation to the onset of exanthem. The onset of neurological complication was observed mostly from day 1 to 3, but in a few case it started blood cells (WBC), C-reactive protein (CRP) tests, and tests of CSF were carried out at Prefectural Gifu Hospital. In patients 1, 2 and 5, these examinations were performed on the 4th day after the onset of illness. In patient 6, sedimentation of RBC and number of WBC were measured on the 2nd day after the onset, and the CRP test and the test of CSF were carried out on the 3rd day after the onset. In patient 3, these examinations were performed on the 6th day after the onset. In patient 4, sedimentation of RBC and CSF were tested on the 6th day after the onset, WBC were counted on the 7th day and the CRP test was made on the 11th day after the onset. The virus isolation was successful from the specimens of patient W. M., but not from the others. The antibody against EV71 was detected in all cases, however a significant rise in the neutralizing antibody titer was found only in one case. All cases had moderate pleocytosis. Protein was in a normal range and the glucose level was normal or slightly increased.
HFMD with Neurological Complication
DISCUSSION
The first epidemic of HFMD due to EV71 occurred in 1973 in Gifu prefecture, where 625 patients with HFMD were confirmed clinically by information from public hospitals. On a part of these cases, virological and serological investigations were performed (Miwa et al., 1978a) .
In 1978, an epidemic of HFMD took place again in Gifu prefecture. The epidemiological information was collected from 11 health centers, and virological and serological investigations were carried out on patients with HFMD in one hospital. The results of these investigations substantiated EV71 as the causative agent of the epidemic of HFMD. The age group affected maximally seems to be slightly older in 1978 than that in the previous outbreaks.
It is of interest that the virus isolation rate from specimens of patients largely depended upon the cells used. EV71 was isolated in Vero cells at a higher rate (40.9%) in 1973, but at a very low rate (2.4%) in 1978. Sugie, Yoshida and Kubota (1978) reported the same results, but Takami et al. (1979a) using Vero cells isolated EV71 from 39% of specimens. The isolation rate of EV71 with MK cells was 26% by Sugie et al. (1978) , 21% by us and 6% by Takami et al. (1979a) . Sugie et al. (1978) reported that there was no significant difference between MK and CMK cells in the isolation rate of EV71, but the virus isolation rate with CMK cells by us was 2.5 times higher than that with MK cells.
A significant rise in the neutralizing antibody titer against the current strain was found in 25% of 24 paired sera in 1973, however, in 56% of 25 of those in 1978. It may have been due to an interference among enteroviruses or simply a reflexion of the time of collection of the 2nd sera. In 1973, a number of other enteroviruses were isolated from clinical specimens of HFMD and convalscent sera were collected 2 weeks after the collection of acute sera. In 1978, however, few enteroviruses were isolated from clinical specimens of HFMD and the 2nd sera were collected 4 weeks after collection of the first sera. OF HFMD CA USED B Y ENTEROVIRUS 71
179 Schmidt et al. (1974) , Blomberg et al. (1975) and Deibel et al. (1975) reported that the new enterovirus (enterovirus 71) was isolated mostly from patients with neurological complication. In Japan, however, the main clinical manifestation of EV71 infection was HFMD, but Gobara et al. (1975) , Miwa et al. (1978a) and Ishimaru et al. (1979) also observed that it was accompanied by neurological complication in the 1973 outbreak. On the other hand, Ishimaru et al. (1979) reported that the cases of HFMD with neurological complication were observed in 81 of 335 cases (24.1%) in 1973 and in 54 of 746 (7.2%) in 1978. In four hospitals in Gifu prefecture, complication was observed in 13 of 351 cases (3.7%). In the Department of Pediatrics of Takayama Red Cross Hospital, the incidence rate of neurological complication was found to be 17 of 84 cases (20.2%) in 1973 and four of 66 cases (6.1%) in 1978, which coincided with the figure reported by Ishimaru et al. (1979) . This may suggest that the 1978 virus had decreased its neurotropic tendency as compared with the 1973 strain. Deguchi, Shingu and Fujimoto (1979) reported that the complication of aseptic meningitis was observed in 21 of 187 cases with HFMD (11.2%). Ishimaru et al. (1979) reported that the onset of CNS disease was observed for 7 days after the onset of exanthem, but Deguchi et al. (1979) reported that it was observed for 5 days, and in our examination it was observed also for 5 days. Ishimaru et al. (1979) and Deguchi et al. (1979) reported that the onset of CNS disease was most frequent within 2-3 days after the onset of exanthem, which was identical with our observation.
As shown in Table VIIIb , the virus isolation rate of HFMD's patients with neurological complication was lower than that of those without complication, however, its cause was remained unexplained. It may be related that specimens from the patients with neurological complication were collected on later days after the onset of illness as compared with specimens from patients without CNS complication. Takami et al. (1979b) reported that virus isolations from the same patients were followed up and viruses were isolated intermittently. We collected specimens from most patients only once, therefore, virus would have been isolated at higher rates if specimens from the same patients had been collected more often.
In the sera of HFMD's patients with CNS involvement, a significant rise in the neutralization antibody titer was found in one of five cases (20%), but in 13 of 20 cases (65%) in sera of those without neurological complication. In the cases with complication, the first sera were collected on later days after the onset in comparison to those without complication. Therefore, the neutralization antibody titer had risen already to higher titers and no significant rise in the antibody titer may have been found apparently. We reported that HFMD's patients had higher titers of the neutralization antibody at an acute phase (1978a). This was probably because HFMD is generally a milder illness and thus patients do not become aware of illness until rash breaks out. Therefore, the onset of illness was very often uncertain, and a high titer of the neutralization antibody might inevitably occur in the first serum specimens.
